Activated T cells Therapy(Kairos)

N/A

Report date: 2025/10/23 20:00:06

Base Information

Drug NameActivated T cells Therapy(Kairos)
Drug Alias NameActivated T cellsATCs
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKairos Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKairos Pharma Ltd
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A